Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
CSIQ Quote, Financials, Valuation and Earnings
Last price:
$12.33
Seasonality move
:
2.57%
Day range:
$12.29 - $12.73
52-week range:
$6.57 - $19.55
Dividend yield:
0%
P/E ratio:
28.55x
P/S ratio:
0.14x
P/B ratio:
0.30x
Volume:
696.6K
Avg. volume:
1.2M
1-year change:
-25.03%
Market cap:
$828.4M
Revenue:
$6B
EPS (TTM):
-$0.50
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5B | $5.3B | $7.5B | $7.6B | $6B | |
| Revenue Growth (YoY) | 8.62% | 51.8% | 41.53% | 1.94% | -21.28% | |
| Cost of Revenues | $2.8B | $4.4B | $6.2B | $6.3B | $5B | |
| Gross Profit | $689.9M | $909.3M | $1.3B | $1.3B | $999.3M | |
| Gross Profit Margin | 19.85% | 17.23% | 16.91% | 16.81% | 16.67% | |
| R&D Expenses | $45.2M | $58.4M | $69.8M | $100.8M | $120.8M | |
| Selling, General & Admin | $449.8M | $707.6M | $901.1M | $810.2M | $1B | |
| Other Inc / (Exp) | -$22.1M | $3.8M | $34.1M | $17.7M | -$3.2M | |
| Operating Expenses | $470.8M | $727.5M | $907.1M | $826.7M | $1B | |
| Operating Income | $219.2M | $181.8M | $356.1M | $453.3M | -$30.1M | |
| Net Interest Expenses | $62.6M | $47.1M | $33.7M | $62.5M | $49M | |
| EBT. Incl. Unusual Items | $134.5M | $138.5M | $356.5M | $408.5M | -$82.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2M | $35.8M | $73.4M | $59.5M | -$16.6M | |
| Net Income to Company | $147.2M | $109.9M | $298.6M | $363.6M | -$77.9M | |
| Minority Interest in Earnings | -$543K | -$14.6M | -$58.6M | -$89.4M | $113.9M | |
| Net Income to Common Excl Extra Items | $146.7M | $95.2M | $240M | $274.2M | $36.1M | |
| Basic EPS (Cont. Ops) | $2.46 | $1.55 | $3.73 | $4.19 | $0.54 | |
| Diluted EPS (Cont. Ops) | $2.38 | $1.46 | $3.44 | $3.87 | $0.54 | |
| Weighted Average Basic Share | $59.6M | $61.6M | $64.3M | $65.4M | $66.6M | |
| Weighted Average Diluted Share | $62.3M | $68.9M | $71.2M | $72.2M | $66.9M | |
| EBITDA | $415.5M | $479.4M | $665.3M | $829.7M | $556.6M | |
| EBIT | $206.4M | $196.6M | $430.7M | $522.6M | $55.2M | |
| Revenue (Reported) | $3.5B | $5.3B | $7.5B | $7.6B | $6B | |
| Operating Income (Reported) | $219.2M | $181.8M | $356.1M | $453.3M | -$30.1M | |
| Operating Income (Adjusted) | $206.4M | $196.6M | $430.7M | $522.6M | $55.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.7B | $1.3B | $1.2B | |
| Revenue Growth (YoY) | 31.94% | 14.78% | 36.07% | -21.88% | -9.97% | |
| Cost of Revenues | $894.7M | $1.1B | $1.4B | $1.1B | $1.1B | |
| Gross Profit | $194.6M | $180.9M | $318M | $252.8M | $140.5M | |
| Gross Profit Margin | 17.86% | 14.47% | 18.69% | 19.02% | 11.74% | |
| R&D Expenses | $12.5M | $13.3M | $17.3M | $34.3M | $24.3M | |
| Selling, General & Admin | $151.5M | $171.7M | $167M | $183.1M | $196.4M | |
| Other Inc / (Exp) | -$5.8M | -$2.4M | -$4.9M | -$3.6M | -$12.5M | |
| Operating Expenses | $151.1M | $165.4M | $172.4M | $203.7M | $195.3M | |
| Operating Income | $43.5M | $15.5M | $145.6M | $49.1M | -$54.8M | |
| Net Interest Expenses | $11.4M | $11.1M | $12.5M | $565K | $28.4M | |
| EBT. Incl. Unusual Items | $26.2M | $2M | $128.2M | $44.9M | -$95.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.9M | -$5.2M | $28.7M | $9.7M | -$23.1M | |
| Net Income to Company | -- | -- | $106.8M | $36.2M | -$76.7M | |
| Minority Interest in Earnings | $9.2M | $273K | -$23.1M | -$23.9M | $42.7M | |
| Net Income to Common Excl Extra Items | $22.8M | $9.2M | $83.7M | $12.4M | -$34M | |
| Basic EPS (Cont. Ops) | $0.38 | $0.14 | $1.30 | $0.19 | -$0.69 | |
| Diluted EPS (Cont. Ops) | $0.36 | $0.14 | $1.19 | $0.19 | -$0.69 | |
| Weighted Average Basic Share | $59.9M | $64M | $64.5M | $66.2M | $67M | |
| Weighted Average Diluted Share | $67.5M | $64.7M | $71.4M | $66.6M | $67M | |
| EBITDA | $40.9M | $17.3M | $148.7M | $79.8M | -$55.2M | |
| EBIT | $40.9M | $17.3M | $148.7M | $79.8M | -$55.2M | |
| Revenue (Reported) | $1.1B | $1.3B | $1.7B | $1.3B | $1.2B | |
| Operating Income (Reported) | $43.5M | $15.5M | $145.6M | $49.1M | -$54.8M | |
| Operating Income (Adjusted) | $40.9M | $17.3M | $148.7M | $79.8M | -$55.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.7B | $5.4B | $7.9B | $7.2B | $5.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.1B | $4.5B | $6.5B | $6B | $5B | |
| Gross Profit | $661.3M | $895.6M | $1.4B | $1.2B | $887.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $47.6M | $59.2M | $73.8M | $117.8M | $110.8M | |
| Selling, General & Admin | $495.8M | $727.7M | $896.4M | $826.2M | $1B | |
| Other Inc / (Exp) | -$14.2M | -$1.4M | $31.6M | $19M | -$12.1M | |
| Operating Expenses | $510.8M | $733.2M | $914.1M | $857.9M | $1B | |
| Operating Income | $150.5M | $162.4M | $486.2M | $356.8M | -$134M | |
| Net Interest Expenses | $57.8M | $46.8M | $35.1M | $50.6M | $76.8M | |
| EBT. Incl. Unusual Items | $78.5M | $114.2M | $482.7M | $325.2M | -$222.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $40.9M | $16.8M | $107.3M | $40.5M | -$49.4M | |
| Net Income to Company | -- | -- | -- | $293M | -$190.7M | |
| Minority Interest in Earnings | $9.3M | -$23.5M | -$82M | -$90.2M | $180.5M | |
| Net Income to Common Excl Extra Items | $58.9M | $81.7M | $314.5M | $202.8M | -$10.3M | |
| Basic EPS (Cont. Ops) | $0.99 | $1.30 | $4.89 | $3.12 | -$0.47 | |
| Diluted EPS (Cont. Ops) | $0.96 | $1.23 | $4.49 | $2.88 | -$0.50 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $146.1M | $173M | $562.1M | $453.7M | -$79.8M | |
| EBIT | $146.1M | $173M | $562.1M | $453.7M | -$79.8M | |
| Revenue (Reported) | $3.7B | $5.4B | $7.9B | $7.2B | $5.9B | |
| Operating Income (Reported) | $150.5M | $162.4M | $486.2M | $356.8M | -$134M | |
| Operating Income (Adjusted) | $146.1M | $173M | $562.1M | $453.7M | -$79.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.7B | $1.3B | $1.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $894.7M | $1.1B | $1.4B | $1.1B | $1.1B | |
| Gross Profit | $194.6M | $180.9M | $318M | $252.8M | $140.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.5M | $13.3M | $17.3M | $34.3M | $24.3M | |
| Selling, General & Admin | $151.5M | $171.7M | $167M | $183.1M | $196.4M | |
| Other Inc / (Exp) | -$5.8M | -$2.4M | -$4.9M | -$3.6M | -$12.5M | |
| Operating Expenses | $151.1M | $165.4M | $172.4M | $203.7M | $195.3M | |
| Operating Income | $43.5M | $15.5M | $145.6M | $49.1M | -$54.8M | |
| Net Interest Expenses | $11.4M | $11.1M | $12.5M | $565K | $28.4M | |
| EBT. Incl. Unusual Items | $26.2M | $2M | $128.2M | $44.9M | -$95.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.9M | -$5.2M | $28.7M | $9.7M | -$23.1M | |
| Net Income to Company | -- | -- | $106.8M | $36.2M | -$76.7M | |
| Minority Interest in Earnings | $9.2M | $273K | -$23.1M | -$23.9M | $42.7M | |
| Net Income to Common Excl Extra Items | $22.8M | $9.2M | $83.7M | $12.4M | -$34M | |
| Basic EPS (Cont. Ops) | $0.38 | $0.14 | $1.30 | $0.19 | -$0.69 | |
| Diluted EPS (Cont. Ops) | $0.36 | $0.14 | $1.19 | $0.19 | -$0.69 | |
| Weighted Average Basic Share | $59.9M | $64M | $64.5M | $66.2M | $67M | |
| Weighted Average Diluted Share | $67.5M | $64.7M | $71.4M | $66.6M | $67M | |
| EBITDA | $40.9M | $17.3M | $148.7M | $79.8M | -$55.2M | |
| EBIT | $40.9M | $17.3M | $148.7M | $79.8M | -$55.2M | |
| Revenue (Reported) | $1.1B | $1.3B | $1.7B | $1.3B | $1.2B | |
| Operating Income (Reported) | $43.5M | $15.5M | $145.6M | $49.1M | -$54.8M | |
| Operating Income (Adjusted) | $40.9M | $17.3M | $148.7M | $79.8M | -$55.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $869.8M | $981.4M | $1.9B | $1.7B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $409M | $651.4M | $971M | $904.9M | $1.1B | |
| Inventory | $696M | $1.2B | $1.5B | $1.2B | $1.2B | |
| Prepaid Expenses | $182.1M | $225.9M | $253.5M | $193.8M | $124.4M | |
| Other Current Assets | $1.1B | $1B | $653.9M | $564.4M | $831M | |
| Total Current Assets | $4.2B | $4.8B | $5.6B | $6.1B | $5.9B | |
| Property Plant And Equipment | $1.3B | $1.6B | $2.3B | $4.3B | $5.5B | |
| Long-Term Investments | $78.3M | $98.8M | $115.8M | $236.9M | $233M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $84.8M | $19M | $17.5M | $19.7M | $31M | |
| Other Long-Term Assets | $577.3M | $611.5M | $636M | $838.7M | $1.1B | |
| Total Assets | $6.5B | $7.4B | $9B | $11.9B | $13.5B | |
| Accounts Payable | $514.7M | $503M | $805.3M | $813.7M | $1.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.4B | $1.6B | $1.4B | $1.8B | $2.1B | |
| Current Portion Of Capital Lease Obligations | $15.2M | $12.2M | $9.8M | $20.2M | $21.3M | |
| Other Current Liabilities | $248.1M | $245.4M | $318.4M | $594.5M | $402.2M | |
| Total Current Liabilities | $3.6B | $4B | $5.3B | $5.9B | $5.4B | |
| Long-Term Debt | $669.3M | $748.3M | $1.1B | $1.7B | $2.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.6B | $5.3B | $6.7B | $8.2B | $9.4B | |
| Common Stock | $687M | $835.5M | $835.5M | $835.5M | $835.5M | |
| Other Common Equity Adj | -$28.7M | -$50.6M | -$170.6M | -$118.7M | -$196.4M | |
| Common Equity | $1.6B | $1.8B | $1.9B | $2.6B | $2.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $322.4M | $325.4M | $365.1M | $1.1B | $1.3B | |
| Total Equity | $1.9B | $2.1B | $2.3B | $3.7B | $4.1B | |
| Total Liabilities and Equity | $6.5B | $7.4B | $9B | $11.9B | $13.5B | |
| Cash and Short Terms | $1.2B | $869.8M | $981.4M | $1.9B | $1.7B | |
| Total Debt | $2.8B | $3.2B | $4B | $4.3B | $5.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $981.2M | $844.6M | $848M | $2.1B | $1.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $395.9M | $728.4M | $991.2M | $809.4M | $919.9M | |
| Inventory | $933.7M | $1.6B | $1.7B | $1.4B | $1.5B | |
| Prepaid Expenses | $230.3M | $287.7M | $345.6M | $228.5M | $186.7M | |
| Other Current Assets | $1.1B | $1.1B | $663.9M | $521.7M | $953.3M | |
| Total Current Assets | $4.4B | $5.7B | $6B | $6.2B | $6B | |
| Property Plant And Equipment | $1.4B | $1.5B | $2.6B | $4.4B | $5.8B | |
| Long-Term Investments | $73.7M | $98.8M | $136.4M | $237.5M | $245.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $82.2M | $88.8M | $14.8M | -- | -- | |
| Other Long-Term Assets | $527.1M | $701.1M | $683.2M | $948.9M | $1.2B | |
| Total Assets | $6.8B | $8.4B | $9.8B | $12.4B | $13.9B | |
| Accounts Payable | $705.1M | $791.2M | $797.9M | $818.2M | $1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.5B | $1.6B | $1.8B | $2.2B | $2.3B | |
| Current Portion Of Capital Lease Obligations | $16.5M | $11.8M | $9.8M | $19.5M | $24.2M | |
| Other Current Liabilities | $169.4M | $198.2M | $409M | $482.7M | $482.5M | |
| Total Current Liabilities | $3.9B | $4.8B | $5.8B | $6B | $5.6B | |
| Long-Term Debt | $690.8M | $978.3M | $1.1B | $2B | $3.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5B | $6.2B | $7.4B | $8.7B | $9.8B | |
| Common Stock | $687M | $835.5M | $835.5M | $835.5M | $835.5M | |
| Other Common Equity Adj | -$53.9M | -$44.3M | -$149.7M | -$166M | -$199.9M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $304.5M | $326.5M | $386.2M | $1.2B | $1.3B | |
| Total Equity | $1.9B | $2.1B | $2.4B | $3.7B | $4.1B | |
| Total Liabilities and Equity | $6.8B | $8.4B | $9.8B | $12.4B | $13.9B | |
| Cash and Short Terms | $981.2M | $844.6M | $848M | $2.1B | $1.6B | |
| Total Debt | $2.9B | $3.9B | $4.5B | $5B | $6.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $147.2M | $109.9M | $298.6M | $363.6M | -$77.9M | |
| Depreciation & Amoritzation | $209.1M | $282.8M | $234.6M | $307M | $501.4M | |
| Stock-Based Compensation | $12.4M | $8.8M | $9.4M | $55.3M | $21.4M | |
| Change in Accounts Receivable | $82.8M | -$384.4M | -$424.5M | $9.4M | -$329.2M | |
| Change in Inventories | -$181M | -$518.7M | -$406.3M | $182.8M | -$312.5M | |
| Cash From Operations | -$120.5M | -$408.3M | $916.6M | $684.6M | -$885.3M | |
| Capital Expenditures | $334.9M | $429.5M | $628M | $1.5B | $1.9B | |
| Cash Acquisitions | $15.3M | -$37M | -$19.4M | -$122.9M | -$39.7M | |
| Cash From Investing | -$319.7M | -$429.6M | -$630.5M | -$1.7B | -$2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.1B | $2.4B | $2.2B | $2.7B | $3.3B | |
| Long-Term Debt Repaid | -$1.6B | -$1.9B | -$1.7B | -$1.6B | -$1.6B | |
| Repurchase of Common Stock | -$6M | -- | -- | -- | -$79.6M | |
| Other Financing Activities | $267.8M | -$7.3M | -$14.5M | $1B | $179.9M | |
| Cash From Financing | $823.5M | $614.1M | $428.6M | $2.1B | $2.3B | |
| Beginning Cash (CF) | $1.2B | $1.6B | $1.4B | $2B | $2.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $383.3M | -$223.8M | $714.8M | $1.1B | -$527.8M | |
| Ending Cash (CF) | $1.6B | $1.4B | $2B | $2.9B | $2.3B | |
| Levered Free Cash Flow | -$455.5M | -$837.8M | $288.6M | -$840.8M | -$2.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $106.8M | $36.2M | -$76.7M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $47.2M | -$291.5M | -$264.2M | |
| Capital Expenditures | -- | -- | $342.9M | $443.4M | $385.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$354M | -$433M | -$469M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$21.4M | |
| Other Financing Activities | -- | -- | $379.7M | $723.4M | $565.6M | |
| Cash From Financing | -- | -- | $379.7M | $723.4M | $544.2M | |
| Beginning Cash (CF) | -- | -- | $2B | $2.9B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | $33.1M | -$51.3M | -$41.2M | |
| Additions / Reductions | -- | -- | $72.9M | -$1M | -$188.9M | |
| Ending Cash (CF) | -- | -- | $2.1B | $2.9B | $2B | |
| Levered Free Cash Flow | -- | -- | -$295.7M | -$734.9M | -$649.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $293M | -$190.7M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $346M | -$858M | |
| Capital Expenditures | -- | -- | $342.9M | $1.6B | $1.8B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$1.8B | -$2B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$21.4M | |
| Other Financing Activities | -- | -- | -- | $1.4B | $22.1M | |
| Cash From Financing | -- | -- | -- | $2.4B | $2.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $992M | -$715.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$1.3B | -$2.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $106.8M | $36.2M | -$76.7M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $47.2M | -$291.5M | -$264.2M | |
| Capital Expenditures | -- | -- | $342.9M | $443.4M | $385.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$354M | -$433M | -$469M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$21.4M | |
| Other Financing Activities | -- | -- | $379.7M | $723.4M | $565.6M | |
| Cash From Financing | -- | -- | $379.7M | $723.4M | $544.2M | |
| Beginning Cash (CF) | -- | -- | $2B | $2.9B | $2.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | $33.1M | -$51.3M | -$41.2M | |
| Additions / Reductions | -- | -- | $72.9M | -$1M | -$188.9M | |
| Ending Cash (CF) | -- | -- | $2.1B | $2.9B | $2B | |
| Levered Free Cash Flow | -- | -- | -$295.7M | -$734.9M | -$649.3M | |
Get CSIQ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CSIQ
Sector
P/E ratio
28.55x
23.75x
PEG ratio
--
0.00x
P/B ratio
0.30x
2.35x
Price / LTM sales
0.14x
1.66x
Growth Metrics
CSIQ
Sector
Revenue growth
-9.97%
3.91%
Earnings growth
-99.16%
11.1%
Revenue (5-year growth)
13.37%
6.27%
Earnings forecast
$0.87
$0.12
Profitability
CSIQ
Sector
Profitability FY 2024
$999.3M
$76.5M
Return on invested capital
-0.11%
0.05%
Return on assets
-0.08%
-0.48%
Return on equity
-0.26%
0.73%
Earnings Date
Last Earnings Date
May
15
Next Earnings Date
Aug
22
Estimated Next Earnings Date
Aug
14
Balance Sheet
CSIQ
Sector
Total cash
$1.6B
$48.7M
Short term investments
--
$19.4M
Total assets
$13.5B
$223.8M
Long term debt
$6.1B
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.92% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.03% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 9.69% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
